Dopamine D2 Receptor (DRD2) Rabbit Polyclonal Antibody TA316680 from OriGene Technologies | Biocompare.com

Supplier Images

Dopamine D2 Receptor (DRD2) Rabbit Polyclonal Antibody

Be the first to write a review!

Citations:

Supplier Page from
OriGene Technologies for
Dopamine D2 Receptor (DRD2) Rabbit Polyclonal Antibody

The Dopamine D2 Receptor (DRD2) Rabbit Polyclonal Antibody from OriGene Technologies is a Rabbit Polyclonal antibody to dopamine receptor D2, and DRD2. This antibody recognizes Human, and Non-Human Primate antigen. The Dopamine D2 Receptor (DRD2) Rabbit Polyclonal Antibody has been validated for the following applications: Immunohistochemistry.

Description

Dopamine D2 Receptor / DRD2 Rabbit Polyclonal (Cytoplasmic Domain) Antibody

Product Specs
ItemDopamine D2 Receptor (DRD2) Rabbit Polyclonal Antibody
CompanyOriGene Technologies
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberTA316680
Quantity50 µg
ApplicationsIHC
Concentrationlot specific
Conjugate/TagUnconjugated
PurityImmunoaffinity Chromatography
ReactivityChimpanzee, Gorilla, Human
TargetDRD2
IsotypeIgG
HostRabbit
Antibody TypePrimary Antibodies
ImmunogenDRD2 / Dopamine Receptor D2 antibody was raised against synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human DRD2. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%); Gibbon, Monkey, Rabbit (95%); Dog, Bovine, Panda, Horse, Pig (89%); Mouse, Rat, Ferret, Bat, Hamster, Elephant (84%)
NCBI Full Gene Namedopamine receptor D2
NCBI Gene AliasesD2R, D2DR
ClonalityPolyclonal
TypePrimary Antibodies
FormatPBS, 0.1% sodium azide

Specifications/Features

Purification: Immunoaffinity Chromatography

Add to Compare List

OriGene Technologies

OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

Company Profile

Website: http://www.origene.com

(1) Dopamine induces in vitro migration of synovial fibroblast from patients with rheumatoid arthritisScientific reportsJuly 17, 2020van Nie L, Salinas-Tejedor L, Dychus N, Fasbender F, Hülser ML, Cutolo M, Rehart S, Neumann E, Müller-Ladner U, Capellino S.

(2) Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitaryPituitaryFebruary 1, 2019Soukup J, Kasparova P, Kohout A, Rychly B, Skarkova V, Syrucek M, Gabalec F.

Be the First to Write a Review!